Top Valeant Holder Bill Ackman to Discuss Investment on Call

Updated on
  • Valeant shares rise 3.6 percent in early trading Tuesday
  • Ackman added 2 million shares of battered company last week

Bill Ackman, the billionaire activist investor, will discuss his holding in Valeant Pharmaceuticals International Inc. on a conference call with other investors Friday.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.